Publikasjoner

Upfront Radiosurgery vs a Wait-and-Scan Approach for Small-or Medium-Sized Vestibular Schwannoma: The V-REX Randomized Clinical Trial.
Dhayalan D; Tveiten ØV;  Finnkirk, M; Storstein, A; Hufthammer, KO; Goplen, FK; Lund-Johansen, M. (2023).  JAMA, 330(5), 421-431.  doi:10.1001/jama.2023.12222

Salvage radiosurgery following subtotal resection of vestibular schwannomas: does timing influence tumor control? 
Dhayalan D, Perry A, Graffeo CS, Tveiten ØV, Muñoz Casabella A, Pollock BE, Driscoll CLW, Carlson ML, Link MJ, Lund-Johansen M. J Neurosurg. 2022 Jul 29:1-10. doi: 10.3171/2022.5.JNS22249. ​

Genetic alterations associated with malignant transformation of sporadic vestibular schwannoma. 
Håvik AL, Bruland O, Miletic H, Poulsgaard L, Scheie D, Fugleholm K, Lund-Johansen M, Knappskog PM. Acta Neurochir (Wien). 2022 Feb;164(2):343-352. doi: 10.1007/s00701-021-05062-0. Epub 2021 Nov 24.

The SH3PXD2A-HTRA1 fusion transcript is extremely rare in Norwegian sporadic vestibular schwannoma patients.  
Taule-Sivertsen P, Bruland O, Håvik AL, Bratland E, Lund-Johansen M, Knappskog PM. J Neurooncol. 2021 Aug;154(1):35-40. doi: 10.1007/s11060-021-03796-6. Epub 2021 Jul 2.

Postural Sway Predicts Growth in Untreated Vestibular Schwannoma: A Retrospective Volumetric Study.
Nilsen KS, Dhayalan D, Lund-Johansen M, Goplen FK. Otol Neurotol. 2021 Apr 1;42(4):e495-e502. doi: 10.1097/MAO.0000000000003032.

​Comparing the impact of upfront radiosurgery versus expectation in vestibular schwannoma (the V-REX study): protocol for a randomised, observer-blinded, 4-year, parallel-group, single-centre, superiority study
Dhayalan D, Tveiten ØV, Goplen FK, Finnkirk M, Storstein AM, Gruner ER, Lund-Johansen M. BMJ Open. 2021 Mar 17;11(3):e039396. doi: 10.1136/bmjopen-2020-039396​

Gamma Knife Radiosurgery does not alter the copy number aberration profile in sporadic vestibular schwannoma.
Håvik AL, Bruland O, Dhayalan D, Lund-Johansen M, Knappskog PM. J Neurooncol. 2020 Sep;149(3):373-381. doi: 10.1007/s11060-020-03631-4. Epub 2020 Sep 27.

EANO guideline on the diagnosis and treatment of vestibular schwannoma. ​Goldbrunner R, Weller M, Regis J, Lund-Johansen M, Stavrinou P, Reuss D, Evans DG, Lefranc F, Sallabanda K, Falini A, Axon P, Sterkers O, Fariselli L, Wick W, Tonn JC. Neuro Oncol. 2020 Jan 11;22(1):31-45. doi: 10.1093/neuonc/noz153.

Fatigue in patients with vestibular schwannoma.
Dhayalan D, Lund-Johansen M, Finnkirk M, Tveiten ØV. Acta Neurochir (Wien). 2019 Sep;161(9):1809-1816. doi: 10.1007/s00701-019-04003-2. Epub 2019 Jul 18.

Long-term Effects of Conservative Management of Vestibular Schwannoma on Dizziness, Balance, and Caloric Function.
Nilsen KS, Lund-Johansen M, Nordahl SHG, Finnkirk M, Goplen FK. Otolaryngol Head Neck Surg. 2019 Nov;161(5):846-851. doi: 10.1177/0194599819860831. Epub 2019 Jul 16.

Treatment of small and medium-sized vestibular schwannoma-a need for better evidence.
Lund-Johansen M. Acta Neurochir (Wien). 2019 Jan;161(1):87-89. doi: 10.1007/s00701-018-3742-2. Epub 2018 Nov 22.

Screening for viral nucleic acids in vestibular schwannoma.
Håvik AL, Bruland O, Aarhus M, Kalland KH, Stokowy T, Lund-Johansen M, Knappskog PM. J Neurovirol. 2018 Dec;24(6):730-737. doi: 10.1007/s13365-018-0669-6. Epub 2018 Aug 30.

Patient Motivation and Long-Term Satisfaction with Treatment Choice in Vestibular Schwannoma. 
Carlson ML, Tveiten ØV, Lund-Johansen M, Tombers NM, Lohse CM, Link MJ. World Neurosurg. 2018 Jun;114:e1245-e1252. doi: 10.1016/j.wneu.2018.03.182. Epub 2018 Apr 3.

Quality of Life in Patients with Vestibular Schwannomas Following Gross Total or Less than Gross Total Microsurgical Resection: Should We be Taking the Entire Tumor Out?Link MJ, Lund-Johansen M, Lohse CM, Driscoll CLW, Myrseth E, Tveiten OV, Carlson ML. Neurosurgery. 2018 Apr 1;82(4):541-547. doi: 10.1093/neuros/nyx245.

Genetic landscape of sporadic vestibular schwannoma.
Håvik AL, Bruland O, Myrseth E, Miletic H, Aarhus M, Knappskog PM, Lund-Johansen M. J Neurosurg. 2018 Mar;128(3):911-922. doi: 10.3171/2016.10.JNS161384. Epub 2017 Apr 14.

Awake craniotomy for vestibular schwannoma.
Lund-Johansen M. Acta Neurochir (Wien). 2017 Sep;159(9):1587-1588. doi: 10.1007/s00701-017-3238-5. Epub 2017 Jun 14.

Surgical salvage of recurrent vestibular schwannoma following prior stereotactic radiosurgery. 
Wise SC, Carlson ML, Tveiten ØV, Driscoll CL, Myrseth E, Lund-Johansen M, Link MJ. Laryngoscope. 2016 Nov;126(11):2580-2586. doi: 10.1002/lary.25943. Epub 2016 Apr 23. 

Risk factors and analysis of long-term headache in sporadic vestibular schwannoma: a multicenter cross-sectional study.
Carlson ML, Tveiten ØV, Driscoll CL, Boes CJ, Sullan MJ, Goplen FK, Lund-Johansen M, Link MJ. J Neurosurg. 2015 Nov;123(5):1276-86. doi: 10.3171/2014.12.JNS142109. Epub 2015 Jun 19.

The Minimal Clinically Important Difference in Vestibular Schwannoma Quality-of-Life Assessment: An Important Step beyond P < .05. 
Carlson ML, Tveiten ØV, Yost KJ, Lohse CM, Lund-Johansen M, Link MJ. Otolaryngol Head Neck Surg. 2015 Aug;153(2):202-8. doi: 10.1177/0194599815585508. Epub 2015 Jun 2.

Long-term Auditory Symptoms in Patients With Sporadic Vestibular Schwannoma: An International Cross-Sectional Study.
Tveiten OV, Carlson ML, Goplen F, Vassbotn F, Link MJ, Lund-Johansen M. Neurosurgery. 2015 Aug;77(2):218-27; discussion 227. doi: 10.1227/NEU.0000000000000760.

Long-term quality of life in patients with vestibular schwannoma: an international multicenter cross-sectional study comparing microsurgery, stereotactic radiosurgery, observation, and nontumor controls.
Carlson ML, Tveiten OV, Driscoll CL, Goplen FK, Neff BA, Pollock BE, Tombers NM, Castner ML, Finnkirk MK, Myrseth E, Pedersen PH, Lund-Johansen M, Link MJ. J Neurosurg. 2015 Apr;122(4):833-42. doi: 10.3171/2014.11.JNS14594. Epub 2015 Jan 2.

What drives quality of life in patients with sporadic vestibular schwannoma?
Carlson ML, Tveiten ØV, Driscoll CL, Goplen FK, Neff BA, Pollock BE, Tombers NM, Lund-Johansen M, Link MJ. Laryngoscope. 2015 Jul;125(7):1697-702. doi: 10.1002/lary.25110. Epub 2014 Dec 27.

Predictors of vertigo in patients with untreated vestibular schwannoma.
Andersen JF, Nilsen KS, Vassbotn FS, Møller P, Myrseth E, Lund-Johansen M, Goplen FK. Otol Neurotol. 2015 Apr;36(4):647-52. doi: 10.1097/MAO.0000000000000668

Long-term Dizziness Handicap in Patients with Vestibular Schwannoma: A Multicenter Cross-sectional Study.
Carlson ML, Tveiten OV, Driscoll CL, Neff BA, Shepard NT, Eggers SD, Staab JP, Tombers NM, Goplen FK, Lund-Johansen M, Link MJ. Otolaryngol Head Neck Surg. 2014 Dec;151(6):1028-37. doi: 10.1177/0194599814551132. Epub 2014 Oct 1.

Conservative management or gamma knife radiosurgery for vestibular schwannoma: tumor growth, symptoms, and quality of life. 
Breivik CN, Nilsen RM, Myrseth E, Pedersen PH, Varughese JK, Chaudhry AA, Lund-Johansen M. Neurosurgery. 2013 Jul;73(1):48-56; discussion 56-7. doi: 10.1227/01.neu.0000429862.50018.b9.

Working disability in Norwegian patients with vestibular schwannoma: vertigo predicts future dependence.
Breivik CN, Nilsen RM, Myrseth E, Finnkirk MK, Lund-Johansen M.
World Neurosurg. 2013 Dec;80(6):e301-5. doi: 10.1016/j.wneu.2013.03.069. Epub 2013 Mar 30

Gamma knife treatment of growing vestibular schwannoma in Norway: a prospective study.
Varughese JK, Wentzel-Larsen T, Pedersen PH, Mahesparan R, Lund-Johansen M.
Int J Radiat Oncol Biol Phys. 2012 Oct 1;84(2):e161-6. doi: 10.1016/j.ijrobp.2012.03.047. Epub 2012 Jun 8.

Growth of untreated vestibular schwannoma: a prospective study.
Varughese JK, Breivik CN, Wentzel-Larsen T, Lund-Johansen M.
J Neurosurg. 2012 Apr;116(4):706-12. doi: 10.3171/2011.12.JNS111662. Epub 2012 Jan 20.

Conservative management of vestibular schwannoma--a prospective cohort study: treatment, symptoms, and quality of life.
Breivik CN, Varughese JK, Wentzel-Larsen T, Vassbotn F, Lund-Johansen M.
Neurosurgery. 2012 May;70(5):1072-80; discussion 1080. doi: 10.1227/NEU.0b013e31823f5afa.

Growth of untreated vestibular schwannoma: a prospective study.
Varughese JK, Breivik CN, Wentzel-Larsen T, Lund-Johansen M.
J Neurosurg. 2012 Apr;116(4):706-12. doi: 10.3171/2011.12.JNS111662. Epub 2012 Jan 20.​

Global gene expression profiling and tissue microarray reveal novel candidate genes and down-regulation of the tumor suppressor gene CAV1 in sporadic vestibular schwannomas.
Aarhus M, Bruland O, Sætran HA, Mork SJ, Lund-Johansen M, Knappskog PM.
Neurosurgery. 2010 Oct;67(4):998-1019; discussion 1019. doi: 10.1227/NEU.0b013e3181ec7b71

Analysis of vestibular schwannoma size in multiple dimensions: a comparative cohort study of ​different measurement techniques.
Varughese JK, Wentzel-Larsen T, Vassbotn F, Moen G, Lund-Johansen M.
Clin Otolaryngol. 2010 Apr;35(2):97-103. doi: 10.1111/j.1749-4486.2010.02099.x.​

Vestibular schwannoma: surgery or gamma knife radiosurgery? A prospective, nonrandomized study.
Myrseth E, Møller P, Pedersen PH, Lund-Johansen M.
Neurosurgery. 2009 Apr;64(4):654-61; discussion 661-3. doi: 10.1227/01.NEU.0000340684.60443.55

Treatment of vestibular schwannomas. Why, when and how?
Myrseth E, Pedersen PH, Møller P, Lund-Johansen M.
Acta Neurochir (Wien). 2007;149(7):647-60; discussion 660. Epub 2007 Jun 11. Review

Untreated vestibular schwannomas: vertigo is a powerful predictor for health-related quality of life.
Myrseth E, Møller P, Wentzel-Larsen T, Goplen F, Lund-Johansen M.
Neurosurgery. 2006 Jul;59(1):67-76; discussion 67-76.

Vestibular schwannomas: clinical results and quality of life after microsurgery or gamma knife radiosurgery.
Myrseth E, Møller P, Pedersen PH, Vassbotn FS, Wentzel-Larsen T, Lund-Johansen M.
Neurosurgery. 2005 May;56(5):927-35; discussion 927-35.